account_balance
Investment manager · 13F filer · SEC CIK 1496201
Sphera Funds Management Ltd.
Reported value$699Mas of Jun 30, 2026
Positions97 22 new, 17 sold out
Top 10 weight36%TEVA alone is 7%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
TEVA
Teva Pharmaceutical Inds Ltd
7.3%Added
MLYS
Mineralys Therapeutics INC
5.7%Added
TSEM
Tower Semiconductor Ltd
4.0%Trimmed
SNDX
Syndax Pharmaceuticals INC
3.2%Added
BIIB
Biogen INC
3.0%Added
RARE
Ultragenyx Pharmaceutical In
2.8%Trimmed
BMRN
Biomarin Pharmaceutical INC
2.7%Added
CYTK
Cytokinetics INC
2.7%Added
BBIO
Bridgebio Pharma INC
2.6%
COGT
Cogent Biosciences INC
2.5%Added
87 others
63.5%
Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed